UPDATE 1-House Democrats launch probe into MS drug pricing

NEW YORK, Aug 17 (Reuters) - Democrats on the House Committee on Oversight and Government Reform said on Thursday they are launching an investigation into why prices for Multiple Sclerosis (MS) treatments have nearly quadrupled since 2004, and they sent letters requesting information from seven drugmakers.